Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03845686 · ClinicalTrials.gov registry record
Brain Markers Predicting Reading Recovery After Stroke
A clinical trial, sponsored by Kessler Foundation.
- Completed
- Registry status
- 26
- Enrollment target
NCT03845686: Completed study, sponsored by Kessler Foundation.
NCT03845686 is a clinical trial that has completed, run by Kessler Foundation. The registered enrollment target is 26 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03845686 has completed, sponsored by Kessler Foundation.
- COMPLETED
- Registry status
- 26 participants
- Enrollment target
Study Summary
For millions of stroke survivors acquired reading deficits represent a significant handicap preventing them from returning to work or continuing their education. The goal of the proposed research is to investigate what brain mechanisms enable recovery of impaired reading. To achieve this goal, the project will directly measure changes in brain perfusion (blood flow) and activation among recovering stroke survivors using a neuroimaging technique called perfusion fMRI (functional Magnetic Resonance Imaging). The project will test if re-perfusion (return of circulation) and re-appearance of reading-related brain activity in the left-brain network for reading is associated with recovery. The ability to predict recovery from neuroimaging has tremendous value in rehabilitation for generating prognoses. It may also dramatically improve the quality of research evaluation for novel, targeted interventions such as noninvasive brain stimulation or pharmacologic therapies.
Primary Outcome
Percent correct of single words read aloud
Interventions
- DIAGNOSTIC_TEST Perfusion functional Magnetic Resonance Imaging (perfusion fMRI)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 26 participants |
| Start Date | 2018-04-04 |
| Est. Completion | 2021-07-01 |
What the finished NCT03845686 record still lists
NCT03845686 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 26 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Perfusion functional Magnetic Resonance Imaging (perfusion fMRI) is the first listed.
NCT03845686 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03845686 about?
NCT03845686 is a clinical study titled "Brain Markers Predicting Reading Recovery After Stroke". For millions of stroke survivors acquired reading deficits represent a significant handicap preventing them from returning to work or continuing their education. The goal of the proposed research is to investigate what brain mechanisms enable recovery of impaired reading. To achieve this goal, the p...
What is the current status of trial NCT03845686?
This trial is currently completed. The enrollment target is 26 participants. The study started on 2018-04-04. Estimated completion is 2021-07-01.
What interventions are being tested in trial NCT03845686?
The interventions under investigation include: Perfusion functional Magnetic Resonance Imaging (perfusion fMRI) (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT03845686?
This trial is sponsored by Kessler Foundation, which has 104 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02646475 · 26 participants · Phase 1
Metabolic Effects of Angiotensin-(1-7)
- NCT03603223 · 26 participants · Phase 2
Pembrolizumab in Treating Participants With Leukoplakia
- NCT04063592 · 26 participants · NA
AMI Construction in Lower Extremity Residual Limbs
- NCT04906460 · 26 participants · Phase 1
Open-label Study of WVE-N531 in Patients With Duchenne Muscular Dystrophy (FORWARD-53)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI